| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 3.09e-11 | 5 | 33 | 4 | GO:0052871 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 2.16e-10 | 7 | 33 | 4 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 2.16e-10 | 7 | 33 | 4 | GO:0018685 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 1.29e-09 | 10 | 33 | 4 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 1.29e-09 | 10 | 33 | 4 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 1.29e-09 | 10 | 33 | 4 | GO:0102033 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 4.37e-09 | 13 | 33 | 4 | GO:0016713 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 1.63e-08 | 49 | 33 | 5 | GO:0016712 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 6.42e-08 | 24 | 33 | 4 | GO:0008392 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 1.06e-07 | 27 | 33 | 4 | GO:0008391 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 1.06e-07 | 239 | 33 | 7 | GO:0031406 | |
| GeneOntologyMolecularFunction | organic acid binding | 1.60e-07 | 254 | 33 | 7 | GO:0043177 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 2.58e-07 | 164 | 33 | 6 | GO:0046906 | |
| GeneOntologyMolecularFunction | iron ion binding | 2.77e-07 | 166 | 33 | 6 | GO:0005506 | |
| GeneOntologyMolecularFunction | aromatase activity | 3.12e-07 | 35 | 33 | 4 | GO:0070330 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 5.42e-07 | 40 | 33 | 4 | GO:0016709 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 6.93e-07 | 194 | 33 | 6 | GO:0016705 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 8.47e-07 | 107 | 33 | 5 | GO:0033293 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 1.21e-06 | 115 | 33 | 5 | GO:0004497 | |
| GeneOntologyMolecularFunction | arachidonate binding | 1.85e-06 | 15 | 33 | 3 | GO:0050544 | |
| GeneOntologyMolecularFunction | icosanoid binding | 2.27e-06 | 16 | 33 | 3 | GO:0050542 | |
| GeneOntologyMolecularFunction | icosatetraenoic acid binding | 2.27e-06 | 16 | 33 | 3 | GO:0050543 | |
| GeneOntologyMolecularFunction | 20-hydroxy-leukotriene B4 omega oxidase activity | 2.65e-06 | 2 | 33 | 2 | GO:0097258 | |
| GeneOntologyMolecularFunction | 20-aldehyde-leukotriene B4 20-monooxygenase activity | 2.65e-06 | 2 | 33 | 2 | GO:0097259 | |
| GeneOntologyMolecularFunction | heme binding | 5.10e-06 | 154 | 33 | 5 | GO:0020037 | |
| GeneOntologyMolecularFunction | long-chain fatty acid binding | 1.31e-05 | 28 | 33 | 3 | GO:0036041 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | 2.68e-05 | 766 | 33 | 8 | GO:0016491 | |
| GeneOntologyMolecularFunction | fatty acid binding | 2.00e-04 | 69 | 33 | 3 | GO:0005504 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 5.06e-04 | 884 | 33 | 7 | GO:0004930 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 9.75e-04 | 28 | 33 | 2 | GO:0001972 | |
| GeneOntologyMolecularFunction | lipid binding | 9.80e-04 | 988 | 33 | 7 | GO:0008289 | |
| GeneOntologyMolecularFunction | spectrin binding | 1.44e-03 | 34 | 33 | 2 | GO:0030507 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 1.52e-03 | 35 | 33 | 2 | GO:0015020 | |
| GeneOntologyMolecularFunction | vitamin binding | 2.35e-03 | 161 | 33 | 3 | GO:0019842 | |
| GeneOntologyMolecularFunction | FAD binding | 2.40e-03 | 44 | 33 | 2 | GO:0071949 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 2.84e-03 | 1189 | 33 | 7 | GO:0046914 | |
| GeneOntologyMolecularFunction | retinoid binding | 2.85e-03 | 48 | 33 | 2 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 2.97e-03 | 49 | 33 | 2 | GO:0019840 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 5.02e-03 | 211 | 33 | 3 | GO:0016758 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 5.80e-03 | 1353 | 33 | 7 | GO:0004888 | |
| GeneOntologyMolecularFunction | flavin adenine dinucleotide binding | 1.05e-02 | 94 | 33 | 2 | GO:0050660 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 1.18e-02 | 288 | 33 | 3 | GO:0016757 | |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 8.12e-11 | 6 | 33 | 4 | GO:0036101 | |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 1.89e-10 | 7 | 33 | 4 | GO:0036102 | |
| GeneOntologyBiologicalProcess | leukotriene catabolic process | 3.78e-10 | 8 | 33 | 4 | GO:0036100 | |
| GeneOntologyBiologicalProcess | icosanoid catabolic process | 1.78e-09 | 11 | 33 | 4 | GO:1901523 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid catabolic process | 2.66e-09 | 12 | 33 | 4 | GO:0042758 | |
| GeneOntologyBiologicalProcess | menaquinone catabolic process | 3.73e-09 | 3 | 33 | 3 | GO:0042361 | |
| GeneOntologyBiologicalProcess | menaquinone metabolic process | 1.49e-08 | 4 | 33 | 3 | GO:0009233 | |
| GeneOntologyBiologicalProcess | phylloquinone metabolic process | 1.49e-08 | 4 | 33 | 3 | GO:0042374 | |
| GeneOntologyBiologicalProcess | phylloquinone catabolic process | 1.49e-08 | 4 | 33 | 3 | GO:0042376 | |
| GeneOntologyBiologicalProcess | vitamin K catabolic process | 1.49e-08 | 4 | 33 | 3 | GO:0042377 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 3.19e-08 | 21 | 33 | 4 | GO:0042182 | |
| GeneOntologyBiologicalProcess | fatty acid derivative catabolic process | 3.89e-08 | 22 | 33 | 4 | GO:1901569 | |
| GeneOntologyBiologicalProcess | prostaglandin catabolic process | 7.44e-08 | 6 | 33 | 3 | GO:1905344 | |
| GeneOntologyBiologicalProcess | prostanoid catabolic process | 7.44e-08 | 6 | 33 | 3 | GO:0062232 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 5.27e-07 | 41 | 33 | 4 | GO:0006691 | |
| GeneOntologyBiologicalProcess | vitamin K metabolic process | 6.10e-07 | 11 | 33 | 3 | GO:0042373 | |
| GeneOntologyBiologicalProcess | fat-soluble vitamin catabolic process | 8.13e-07 | 12 | 33 | 3 | GO:0042363 | |
| GeneOntologyBiologicalProcess | fat-soluble vitamin metabolic process | 1.29e-06 | 51 | 33 | 4 | GO:0006775 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 1.34e-06 | 14 | 33 | 3 | GO:0097267 | |
| GeneOntologyBiologicalProcess | vitamin metabolic process | 2.12e-06 | 133 | 33 | 5 | GO:0006766 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 2.83e-06 | 141 | 33 | 5 | GO:0006805 | |
| GeneOntologyBiologicalProcess | vitamin catabolic process | 3.00e-06 | 18 | 33 | 3 | GO:0009111 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 4.11e-06 | 68 | 33 | 4 | GO:0019369 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 5.47e-06 | 73 | 33 | 4 | GO:1901616 | |
| GeneOntologyBiologicalProcess | fatty acid derivative metabolic process | 8.70e-06 | 82 | 33 | 4 | GO:1901568 | |
| GeneOntologyBiologicalProcess | negative regulation of organic acid transport | 1.79e-05 | 32 | 33 | 3 | GO:0032891 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 2.56e-05 | 222 | 33 | 5 | GO:0071466 | |
| GeneOntologyBiologicalProcess | fatty acid catabolic process | 3.43e-05 | 116 | 33 | 4 | GO:0009062 | |
| GeneOntologyBiologicalProcess | vitamin E metabolic process | 3.71e-05 | 6 | 33 | 2 | GO:0042360 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid metabolic process | 4.45e-05 | 124 | 33 | 4 | GO:0001676 | |
| GeneOntologyBiologicalProcess | unsaturated fatty acid metabolic process | 5.04e-05 | 128 | 33 | 4 | GO:0033559 | |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 6.91e-05 | 8 | 33 | 2 | GO:0070980 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 7.54e-05 | 142 | 33 | 4 | GO:0006690 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid catabolic process | 8.18e-05 | 145 | 33 | 4 | GO:0072329 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 1.11e-04 | 10 | 33 | 2 | GO:0018879 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 1.62e-04 | 12 | 33 | 2 | GO:0052697 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 1.88e-04 | 180 | 33 | 4 | GO:0120254 | |
| GeneOntologyBiologicalProcess | lipid catabolic process | 3.29e-04 | 382 | 33 | 5 | GO:0016042 | |
| GeneOntologyBiologicalProcess | renal system process involved in regulation of blood volume | 3.74e-04 | 18 | 33 | 2 | GO:0001977 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 5.11e-04 | 21 | 33 | 2 | GO:0052695 | |
| GeneOntologyBiologicalProcess | negative regulation of amino acid transport | 5.11e-04 | 21 | 33 | 2 | GO:0051956 | |
| GeneOntologyBiologicalProcess | small molecule catabolic process | 5.12e-04 | 421 | 33 | 5 | GO:0044282 | |
| GeneOntologyBiologicalProcess | epoxygenase P450 pathway | 5.62e-04 | 22 | 33 | 2 | GO:0019373 | |
| GeneOntologyBiologicalProcess | regulation of organic acid transport | 5.92e-04 | 103 | 33 | 3 | GO:0032890 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 7.88e-04 | 26 | 33 | 2 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 7.88e-04 | 26 | 33 | 2 | GO:0006063 | |
| GeneOntologyBiologicalProcess | organic acid catabolic process | 8.96e-04 | 272 | 33 | 4 | GO:0016054 | |
| GeneOntologyBiologicalProcess | carboxylic acid catabolic process | 8.96e-04 | 272 | 33 | 4 | GO:0046395 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | 9.48e-04 | 731 | 33 | 6 | GO:0032787 | |
| GeneOntologyBiologicalProcess | ketone metabolic process | 9.84e-04 | 279 | 33 | 4 | GO:0042180 | |
| GeneOntologyBiologicalProcess | renal system process involved in regulation of systemic arterial blood pressure | 1.12e-03 | 31 | 33 | 2 | GO:0003071 | |
| GeneOntologyBiologicalProcess | organic acid metabolic process | 1.25e-03 | 1064 | 33 | 7 | GO:0006082 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | 1.30e-03 | 1395 | 33 | 8 | GO:0007186 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | 1.38e-03 | 525 | 33 | 5 | GO:0009410 | |
| GeneOntologyBiologicalProcess | very long-chain fatty acid metabolic process | 1.43e-03 | 35 | 33 | 2 | GO:0000038 | |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 1.60e-03 | 37 | 33 | 2 | GO:0042537 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 1.60e-03 | 37 | 33 | 2 | GO:0042178 | |
| GeneOntologyBiologicalProcess | androgen metabolic process | 1.68e-03 | 38 | 33 | 2 | GO:0008209 | |
| GeneOntologyBiologicalProcess | negative regulation of amine transport | 2.15e-03 | 43 | 33 | 2 | GO:0051953 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | 2.17e-03 | 582 | 33 | 5 | GO:0050906 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 3.13e-03 | 52 | 33 | 2 | GO:0008210 | |
| GeneOntologyBiologicalProcess | cellular catabolic process | 3.18e-03 | 1253 | 33 | 7 | GO:0044248 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | 3.29e-03 | 641 | 33 | 5 | GO:1901615 | |
| GeneOntologyBiologicalProcess | regulation of amino acid transport | 4.15e-03 | 60 | 33 | 2 | GO:0051955 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | UGT2B15 UGT2B17 CYP4F2 CYP4F3 CYP4F12 CYP2R1 PLOD1 CYP4F11 AQP11 | 1.28e-04 | 1293 | 33 | 9 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | UGT2B15 UGT2B17 CYP4F2 CYP4F3 CYP4F12 CYP2R1 PLOD1 CYP4F11 AQP11 | 1.33e-04 | 1299 | 33 | 9 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | UGT2B15 UGT2B17 CYP4F2 CYP4F3 CYP4F12 CYP2R1 PLOD1 CYP4F11 AQP11 | 1.56e-04 | 1327 | 33 | 9 | GO:0042175 |
| GeneOntologyCellularComponent | calyx of Held | 1.47e-03 | 36 | 33 | 2 | GO:0044305 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 1.82e-03 | 40 | 33 | 2 | GO:0005640 | |
| GeneOntologyCellularComponent | nuclear membrane | 2.13e-03 | 349 | 33 | 4 | GO:0031965 | |
| MousePheno | persistence of hyaloid vascular system | 3.28e-05 | 223 | 24 | 5 | MP:0001289 | |
| MousePheno | abnormal retina blood vessel morphology | 4.13e-05 | 234 | 24 | 5 | MP:0010097 | |
| MousePheno | decreased synaptic depression | 2.18e-04 | 13 | 24 | 2 | MP:0002917 | |
| Domain | Cyt_P450_E_grp-I | 1.24e-08 | 45 | 32 | 5 | IPR002401 | |
| Domain | Cyt_P450_CS | 2.88e-08 | 53 | 32 | 5 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 4.18e-08 | 57 | 32 | 5 | PS00086 | |
| Domain | - | 4.57e-08 | 58 | 32 | 5 | 1.10.630.10 | |
| Domain | p450 | 4.57e-08 | 58 | 32 | 5 | PF00067 | |
| Domain | Cyt_P450 | 5.44e-08 | 60 | 32 | 5 | IPR001128 | |
| Domain | UDPGT | 5.85e-04 | 21 | 32 | 2 | PS00375 | |
| Domain | UDPGT | 5.85e-04 | 21 | 32 | 2 | PF00201 | |
| Domain | UDP_glucos_trans | 5.85e-04 | 21 | 32 | 2 | IPR002213 | |
| Domain | GPCR_Rhodpsn_7TM | 8.51e-04 | 670 | 32 | 6 | IPR017452 | |
| Domain | 7tm_1 | 8.98e-04 | 677 | 32 | 6 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 9.54e-04 | 685 | 32 | 6 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 9.99e-04 | 691 | 32 | 6 | PS50262 | |
| Domain | GPCR_Rhodpsn | 1.01e-03 | 692 | 32 | 6 | IPR000276 | |
| Domain | MFS | 7.68e-03 | 77 | 32 | 2 | IPR011701 | |
| Domain | MFS_1 | 7.68e-03 | 77 | 32 | 2 | PF07690 | |
| Domain | MFS | 1.47e-02 | 108 | 32 | 2 | PS50850 | |
| Domain | 7TM_GPCR_Srsx | 1.57e-02 | 112 | 32 | 2 | SM01381 | |
| Domain | MFS_dom | 2.20e-02 | 134 | 32 | 2 | IPR020846 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 4.84e-09 | 33 | 28 | 5 | MM15918 | |
| Pathway | REACTOME_EICOSANOIDS | 6.10e-09 | 12 | 28 | 4 | MM14845 | |
| Pathway | REACTOME_EICOSANOIDS | 6.10e-09 | 12 | 28 | 4 | M27129 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 7.10e-09 | 219 | 28 | 8 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 7.36e-09 | 220 | 28 | 8 | M10320 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 1.23e-08 | 14 | 28 | 4 | MM15842 | |
| Pathway | REACTOME_FATTY_ACIDS | 1.67e-08 | 15 | 28 | 4 | M27126 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 3.74e-08 | 18 | 28 | 4 | MM14843 | |
| Pathway | REACTOME_FATTY_ACIDS | 3.74e-08 | 18 | 28 | 4 | MM14841 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 4.60e-08 | 104 | 28 | 6 | M738 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 4.88e-08 | 105 | 28 | 6 | MM14842 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 5.21e-08 | 183 | 28 | 7 | M39588 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 1.27e-07 | 62 | 28 | 5 | M39653 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.49e-07 | 64 | 28 | 5 | M5650 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 1.53e-07 | 25 | 28 | 4 | MM14858 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.74e-07 | 66 | 28 | 5 | MM14839 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 4.90e-07 | 33 | 28 | 4 | MM15963 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 1.15e-06 | 11 | 28 | 3 | MM14863 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 1.53e-06 | 12 | 28 | 3 | M27128 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 6.01e-06 | 61 | 28 | 4 | MM14861 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 9.11e-06 | 21 | 28 | 3 | M27137 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 3.04e-05 | 31 | 28 | 3 | M39851 | |
| Pathway | WP_TRYPTOPHAN_METABOLISM | 1.14e-04 | 48 | 28 | 3 | MM15902 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY | 1.36e-04 | 9 | 28 | 2 | M39819 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 2.12e-04 | 59 | 28 | 3 | M27140 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 3.33e-04 | 170 | 28 | 4 | MM15573 | |
| Pathway | REACTOME_PREDNISONE_ADME | 9.38e-04 | 23 | 28 | 2 | MM16639 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.02e-03 | 24 | 28 | 2 | MM14599 | |
| Pathway | WP_GLUCURONIDATION | 1.11e-03 | 25 | 28 | 2 | MM15820 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.11e-03 | 25 | 28 | 2 | M17787 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 1.11e-03 | 25 | 28 | 2 | M605 | |
| Pathway | WP_GLUCURONIDATION | 1.20e-03 | 26 | 28 | 2 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 1.39e-03 | 28 | 28 | 2 | M19580 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX | 1.49e-03 | 29 | 28 | 2 | M39858 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 2.69e-03 | 39 | 28 | 2 | MM15695 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 2.97e-03 | 41 | 28 | 2 | M7399 | |
| Pathway | WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS | 3.12e-03 | 42 | 28 | 2 | MM15822 | |
| Pathway | WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS | 3.12e-03 | 42 | 28 | 2 | M39703 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 3.27e-03 | 43 | 28 | 2 | MM15873 | |
| Pathway | REACTOME_ASPIRIN_ADME | 3.42e-03 | 44 | 28 | 2 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 3.57e-03 | 45 | 28 | 2 | MM15694 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 4.57e-03 | 51 | 28 | 2 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 4.74e-03 | 52 | 28 | 2 | M14171 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 4.98e-03 | 176 | 28 | 3 | M27854 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 5.29e-03 | 55 | 28 | 2 | M14933 | |
| Pathway | KEGG_ARACHIDONIC_ACID_METABOLISM | 5.87e-03 | 58 | 28 | 2 | M5410 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | 6.86e-03 | 620 | 28 | 5 | MM15193 | |
| Pathway | KEGG_RETINOL_METABOLISM | 7.11e-03 | 64 | 28 | 2 | M9488 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 8.45e-03 | 70 | 28 | 2 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 8.92e-03 | 72 | 28 | 2 | M9257 | |
| Pubmed | Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11. | 6.71e-13 | 4 | 33 | 4 | 18065749 | |
| Pubmed | 1.01e-11 | 6 | 33 | 4 | 9068972 | ||
| Pubmed | 2.35e-11 | 7 | 33 | 4 | 22160543 | ||
| Pubmed | Expression and catalytic activity of mouse leukotriene B4 omega-hydroxylase, CYP4F14. | 3.11e-09 | 4 | 33 | 3 | 11185557 | |
| Pubmed | 3.11e-09 | 4 | 33 | 3 | 22665481 | ||
| Pubmed | 6.49e-09 | 70 | 33 | 5 | 15128046 | ||
| Pubmed | 7.77e-09 | 5 | 33 | 3 | 22969154 | ||
| Pubmed | Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation. | 7.77e-09 | 5 | 33 | 3 | 21466787 | |
| Pubmed | Localization of UDP glucuronosyltransferase gene(s) on mouse chromosome 5. | 8.73e-07 | 2 | 33 | 2 | 3105095 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 17848572 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 24267955 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 24138531 | ||
| Pubmed | Expression of CYP4F2 in human liver and kidney: assessment using targeted peptide antibodies. | 8.73e-07 | 2 | 33 | 2 | 18662666 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 12974671 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 22170718 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 27496708 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 1909870 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 28228532 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 32660355 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 15364545 | ||
| Pubmed | Expression and physiological function of CYP4F subfamily in human eosinophils. | 8.73e-07 | 2 | 33 | 2 | 17980168 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 24121496 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 15666817 | ||
| Pubmed | Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver. | 8.73e-07 | 2 | 33 | 2 | 8026587 | |
| Pubmed | Mouse UDP glucuronosyltransferase. cDNA and complete amino acid sequence and regulation. | 8.73e-07 | 2 | 33 | 2 | 3117546 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 17698910 | ||
| Pubmed | 1.05e-06 | 193 | 33 | 5 | 19343046 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 20736324 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 23223495 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 26385605 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 19572376 | ||
| Pubmed | Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes. | 2.62e-06 | 3 | 33 | 2 | 18302198 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 28882566 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 30689982 | ||
| Pubmed | Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines. | 2.62e-06 | 3 | 33 | 2 | 26163549 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 17988216 | ||
| Pubmed | Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxides. | 2.62e-06 | 3 | 33 | 2 | 15145985 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 18281521 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 26176234 | ||
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 18577768 | ||
| Pubmed | Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. | 1.00e-05 | 44 | 33 | 3 | 12745259 | |
| Pubmed | 1.15e-05 | 46 | 33 | 3 | 25209997 | ||
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 21365123 | ||
| Pubmed | 1.83e-05 | 7 | 33 | 2 | 26074487 | ||
| Pubmed | 2.44e-05 | 8 | 33 | 2 | 22579593 | ||
| Pubmed | 2.44e-05 | 8 | 33 | 2 | 32093886 | ||
| Pubmed | 2.44e-05 | 8 | 33 | 2 | 18719240 | ||
| Pubmed | 2.44e-05 | 8 | 33 | 2 | 20142249 | ||
| Pubmed | 5.22e-05 | 76 | 33 | 3 | 22323595 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 5.73e-05 | 12 | 33 | 2 | 20308471 | |
| Pubmed | ERp57 is essential for efficient folding of glycoproteins sharing common structural domains. | 2.58e-04 | 25 | 33 | 2 | 17170699 | |
| Pubmed | 7.10e-04 | 430 | 33 | 4 | 16303743 | ||
| Pubmed | 8.62e-04 | 197 | 33 | 3 | 21386911 | ||
| Pubmed | 9.00e-04 | 200 | 33 | 3 | 18240029 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.99e-05 | 797 | 33 | 6 | chr19p13 | |
| Cytoband | 4q13 | 5.23e-05 | 15 | 33 | 2 | 4q13 | |
| Cytoband | 6q23 | 5.97e-05 | 16 | 33 | 2 | 6q23 | |
| Cytoband | 19p13.1 | 5.54e-04 | 48 | 33 | 2 | 19p13.1 | |
| Cytoband | 19p13.11 | 1.28e-03 | 73 | 33 | 2 | 19p13.11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q22 | 1.85e-03 | 88 | 33 | 2 | chr17q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q23 | 3.34e-03 | 119 | 33 | 2 | chr6q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | 5.72e-03 | 157 | 33 | 2 | chr4q13 | |
| Cytoband | 14q11.2 | 7.45e-03 | 180 | 33 | 2 | 14q11.2 | |
| GeneFamily | Cytochrome P450 family 4 | 2.25e-07 | 36 | 27 | 4 | 1003 | |
| GeneFamily | UDP glucuronosyltransferases | 1.04e-03 | 32 | 27 | 2 | 363 | |
| GeneFamily | Olfactory receptors, family 4 | 1.58e-02 | 129 | 27 | 2 | 151 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_DN | 1.04e-07 | 190 | 32 | 6 | MM1311 | |
| Coexpression | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN | 1.86e-06 | 20 | 32 | 3 | MM1104 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4 | 2.62e-06 | 330 | 32 | 6 | MM1120 | |
| Coexpression | BOCHKIS_FOXA2_TARGETS | 1.89e-05 | 467 | 32 | 6 | MM1233 | |
| Coexpression | CTIP_DN.V1_DN | 2.10e-05 | 134 | 32 | 4 | M2751 | |
| Coexpression | DESCARTES_ORGANOGENESIS_HEPATOCYTES | 4.06e-05 | 535 | 32 | 6 | MM3635 | |
| Coexpression | HOFFMAN_CLOCK_TARGETS_UP | 6.46e-05 | 10 | 32 | 2 | M2063 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 1.02e-04 | 201 | 32 | 4 | MM1294 | |
| Coexpression | ANDERSEN_LIVER_CANCER_KRT19_DN | 1.05e-04 | 75 | 32 | 3 | M424 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_39 | 1.08e-04 | 204 | 32 | 4 | MM17090 | |
| Coexpression | WOO_LIVER_CANCER_RECURRENCE_DN | 1.18e-04 | 78 | 32 | 3 | M9911 | |
| Coexpression | NFE2L2.V2 | 2.43e-04 | 469 | 32 | 5 | M2870 | |
| ToppCell | Control-Neutrophil|Control / Disease condition and Cell class | 2.25e-06 | 126 | 33 | 4 | 450c01d89714feee6529680ec3ce69067a54b37c | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.25e-06 | 126 | 33 | 4 | 730fc6dc740613b55e40e85334fa30330aa81c3b | |
| ToppCell | Control-Neutrophil-|Control / Disease condition and Cell class | 2.25e-06 | 126 | 33 | 4 | 65fff5ec2296272e94f44546606587833191dd82 | |
| ToppCell | Control-Myeloid_G-Neutrophil|Control / Disease group, lineage and cell class | 2.33e-06 | 127 | 33 | 4 | d4af23d621b546785a077c367c3a66c59749fc15 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.47e-06 | 129 | 33 | 4 | 5578a9ef85706ab6a204ff31716e781ec3893b75 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.55e-06 | 130 | 33 | 4 | 124f76067a2d4448ce06158a769d0d11b0297110 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.55e-06 | 130 | 33 | 4 | cd6d8d646345b01ff0f04f776330a05b82e63bc9 | |
| ToppCell | Control-Myeloid_G|Control / Disease group, lineage and cell class | 2.63e-06 | 131 | 33 | 4 | d5a53431f1f1b283fb9338b8561e6381f0227c62 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.15e-04 | 128 | 33 | 3 | 9b3c57d559a5ed8d590dd89b64a57a3227d8c684 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.15e-04 | 128 | 33 | 3 | 58639cfdc70ff6764adcc5c1ce9eba9d033b8209 | |
| ToppCell | TCGA-Mesothelium|World / Sample_Type by Project: Shred V9 | 1.21e-04 | 130 | 33 | 3 | 3ef1733eb57e2a9a3298ce0d65401f19e2084df1 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.32e-04 | 134 | 33 | 3 | 7b237690a3765d974f6f813ef2d01154bc23b9d6 | |
| ToppCell | COVID-19_Mild-Myeloid_G-Neutrophil|COVID-19_Mild / Disease group, lineage and cell class | 1.35e-04 | 135 | 33 | 3 | e9eb2bebb6d19c439c83f46c12ca0d676db69de8 | |
| ToppCell | COVID-19_Mild-Myeloid_G|COVID-19_Mild / Disease group, lineage and cell class | 1.57e-04 | 142 | 33 | 3 | c8aeb747ed836197265d269aa131fae172b45aec | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.60e-04 | 143 | 33 | 3 | 974260c25dad599eea83a33e83117f7307b92a42 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 148 | 33 | 3 | f85dc34f6a4a15ecffa4fbd5644dea12ce30089b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 148 | 33 | 3 | 4b1fdf90c585f89cee1cf521db4e3fafc9d74d9a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 148 | 33 | 3 | 55826b7e9f79ab78a93abd4fc662bc37aa121471 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D175|Adult / Lineage, Cell type, age group and donor | 1.84e-04 | 150 | 33 | 3 | b0b6ba3686d3eb8a9b249d30be14111de3b893be | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.27e-04 | 161 | 33 | 3 | 7c9d4410d7142a5f3a05418c994f69978c9ffa17 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-04 | 161 | 33 | 3 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-04 | 164 | 33 | 3 | b6df1e67a5ce5f2d86f4e1420f4ee931f760bf4d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-04 | 166 | 33 | 3 | dc443a3327dc8f9a0d808c3c6e06b0834d45f5c2 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.48e-04 | 166 | 33 | 3 | d96c562e1483adb4cdd817b68133f03356d7279b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-04 | 167 | 33 | 3 | b4ef07117d14da3d5fbced949e4dfcb01c392295 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-04 | 167 | 33 | 3 | 94fc7df7ca55cd722a8dbd153201a29891217473 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-04 | 167 | 33 | 3 | eff3723fe60755272eca237459165e436e919ece | |
| ToppCell | healthy_donor-Myeloid-Monocytic-Neutrophil|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.57e-04 | 168 | 33 | 3 | 04259f5a9b067cd1b5619e34591e4b2fccc18535 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-04 | 170 | 33 | 3 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-04 | 170 | 33 | 3 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-04 | 170 | 33 | 3 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-04 | 170 | 33 | 3 | 1f8738acf439d893880db7e1fdc9b3615ca00c39 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-04 | 170 | 33 | 3 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.80e-04 | 173 | 33 | 3 | 7dc988fc0ba29990567bf1bcdeb3faeeee507eb1 | |
| ToppCell | Healthy_Control-Myeloid-Mast-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.90e-04 | 175 | 33 | 3 | eadbbcdf2aef4cee268bc70a7a2c4175d898953b | |
| ToppCell | Healthy_Control-Myeloid-Mast|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.90e-04 | 175 | 33 | 3 | ca187074adcc9b8bd0fa270e2ede1564c8e6c6cf | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.04e-04 | 178 | 33 | 3 | 09475e522dc1b8cf9ff1c25de5d1e3082b162948 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.04e-04 | 178 | 33 | 3 | 35de8f791b0e78a6caf52ff095f05e204a59e828 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.04e-04 | 178 | 33 | 3 | 000d25f3f13cc76cf39c46c312c6fafc2ea4f368 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-04 | 178 | 33 | 3 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-04 | 183 | 33 | 3 | facd6dbe0851b537d70a899ac7485714ab27d071 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.30e-04 | 183 | 33 | 3 | 91079a11685dd466bd27a0cf5afbf3734c08a05e | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 3.35e-04 | 184 | 33 | 3 | b0a251030d127858e68cf164be158f209a4d720f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 185 | 33 | 3 | 7092436b4db90289516ed130ade596e3021cffaf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 185 | 33 | 3 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-Neutrophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.41e-04 | 185 | 33 | 3 | 2c89af7cdf5306b900a5b8ec4fdfb8210e5667ed | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 185 | 33 | 3 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 185 | 33 | 3 | a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.46e-04 | 186 | 33 | 3 | 6568358812f0ca4e0161a1a1b29682fbced35c79 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.46e-04 | 186 | 33 | 3 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | P07-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.57e-04 | 188 | 33 | 3 | 6ec22b79b19d57ea187f312907819dc2d01f3efe | |
| ToppCell | Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.63e-04 | 189 | 33 | 3 | c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9 | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.63e-04 | 189 | 33 | 3 | d69b7a01dd4d6ad043bb6210e9ab34b49578389c | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.63e-04 | 189 | 33 | 3 | 2b5f1b4f173a224342ea4f10b193ee33b7662699 | |
| ToppCell | P03-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.63e-04 | 189 | 33 | 3 | b5439ef221106f6d54434f268485e9bb17b39102 | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.63e-04 | 189 | 33 | 3 | 43e131458d8a4b120f7a5fb3d0c5650abded15f6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.68e-04 | 190 | 33 | 3 | 876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 190 | 33 | 3 | 8cb950effc449ae59a915132ecc079be54d1acfe | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.68e-04 | 190 | 33 | 3 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.68e-04 | 190 | 33 | 3 | be9f36127028f52ca5fc1b32ba15a6c26aad69ac | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 190 | 33 | 3 | 17a73a658fb30a4322b31e38db7b240023738f29 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.68e-04 | 190 | 33 | 3 | 09a8855901c3c9332dbaab3e40166485b696d0f1 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 190 | 33 | 3 | 5dfbd064ab1f8a0b18b5975c47f8e79697f3db15 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-04 | 191 | 33 | 3 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 3.74e-04 | 191 | 33 | 3 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-04 | 191 | 33 | 3 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-04 | 191 | 33 | 3 | 1caf726bd07fdca389e678fc16304a6ef1790423 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-04 | 191 | 33 | 3 | 3d60c46bced2984c27a1fcf2910bc38b31fb0148 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-04 | 191 | 33 | 3 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.80e-04 | 192 | 33 | 3 | 4022f208eb5db760abd0aac782a25e8ab63efc64 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.80e-04 | 192 | 33 | 3 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | P28-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.80e-04 | 192 | 33 | 3 | 87c7780cf72f4c204f2a5f6655309d47a23c08ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.80e-04 | 192 | 33 | 3 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.80e-04 | 192 | 33 | 3 | 9333aba0d04203ccccad78d82bf6359922f810a7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.80e-04 | 192 | 33 | 3 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-04 | 194 | 33 | 3 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.92e-04 | 194 | 33 | 3 | 8f19e553f18c313c2a2ff9453884b9484b255d71 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-04 | 194 | 33 | 3 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.92e-04 | 194 | 33 | 3 | f95935153bd2c4c3c7b2b729da6f7e98b45fed79 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.92e-04 | 194 | 33 | 3 | 7a7406c3b021aeafde423d20290c681c3e8ea0a6 | |
| ToppCell | control-Myeloid-Neutrophils_3|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.92e-04 | 194 | 33 | 3 | 2218e6677dc6781a6e4ef3a315f2298cc2cd9df2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.92e-04 | 194 | 33 | 3 | 67fbb81b7d20cb63be27b2a2beea5b5689f8e08c | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-04 | 195 | 33 | 3 | 79114b3c78cc15c413bb58f0673e7215b784a9b6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-04 | 195 | 33 | 3 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.97e-04 | 195 | 33 | 3 | 815ac5dacd382b11abb32011ed1c0635b0ddc779 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.97e-04 | 195 | 33 | 3 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-04 | 195 | 33 | 3 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.97e-04 | 195 | 33 | 3 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.97e-04 | 195 | 33 | 3 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.97e-04 | 195 | 33 | 3 | b21bf50d689fc3b933182f4bfdde82f375257b72 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-04 | 195 | 33 | 3 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.97e-04 | 195 | 33 | 3 | b5db3c0e3a41f68fca18e0a74e1b7e81df4f94c5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-04 | 196 | 33 | 3 | 5146976881d79642ebe5dcbcf89e0252713a9ef2 | |
| ToppCell | mild-Myeloid-Neutrophils_3|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.03e-04 | 196 | 33 | 3 | 9c351306b6aae68ed47d4cb1911957bf67f9e1ae | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.03e-04 | 196 | 33 | 3 | ce6f7ddb8104471dc90347f427486379914d63b4 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.03e-04 | 196 | 33 | 3 | 6d7179decea512dd49bb2d5f6a4f5989349d52a9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.03e-04 | 196 | 33 | 3 | 73f029d2b276776d6c24356b14c6592c9cb74bd5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-04 | 196 | 33 | 3 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-04 | 196 | 33 | 3 | ebac1d6af7a5732707d82d01285c086b19d8ae62 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-04 | 197 | 33 | 3 | d14e1f2ba94240c61eac435db43508a224d606a8 | |
| Computational | Neighborhood of GSTM1 | 7.41e-04 | 109 | 18 | 3 | GNF2_GSTM1 | |
| Computational | Neighborhood of LCAT | 1.08e-03 | 124 | 18 | 3 | GNF2_LCAT | |
| Computational | Neighborhood of HPN | 1.35e-03 | 134 | 18 | 3 | GNF2_HPN | |
| Computational | Neighborhood of HPX | 1.38e-03 | 135 | 18 | 3 | GNF2_HPX | |
| Drug | AC1Q7AUJ | 2.39e-10 | 117 | 32 | 7 | CID000003303 | |
| Drug | diclofenac | 3.84e-10 | 209 | 32 | 8 | CID000003032 | |
| Drug | hexobarbital | 4.26e-10 | 127 | 32 | 7 | CID000003608 | |
| Drug | dioxin | UGT2B15 UGT2B17 TGM1 CYP4F2 CYP4F3 CYP4F12 CYP2R1 NQO2 CYP4F11 | 8.24e-10 | 347 | 32 | 9 | CID000015625 |
| Drug | aminopyrine | 3.42e-09 | 171 | 32 | 7 | CID000006009 | |
| Drug | benzphetamine | 1.46e-08 | 119 | 32 | 6 | CID000002341 | |
| Drug | 3 -hydroxypregn-5-en-20-one | 3.36e-08 | 238 | 32 | 7 | CID000001027 | |
| Drug | propoxyphene | 3.59e-08 | 67 | 32 | 5 | CID000010100 | |
| Drug | carteolol | 5.17e-08 | 72 | 32 | 5 | CID000002583 | |
| Drug | trimipramine | 8.82e-08 | 80 | 32 | 5 | CID000005584 | |
| Drug | diosmetin | 1.20e-07 | 85 | 32 | 5 | CID005281612 | |
| Drug | mephenytoin | 1.43e-07 | 88 | 32 | 5 | CID000004060 | |
| Drug | tienilic acid | 1.88e-07 | 93 | 32 | 5 | CID000038409 | |
| Drug | lansoprazole | 1.88e-07 | 93 | 32 | 5 | CID000003883 | |
| Drug | clofibrate | 2.08e-07 | 311 | 32 | 7 | CID000002796 | |
| Drug | alprazolam | 2.59e-07 | 193 | 32 | 6 | CID000002118 | |
| Drug | AC1L1KIN | 2.71e-07 | 100 | 32 | 5 | CID000005516 | |
| Drug | Sparteinum | 2.85e-07 | 101 | 32 | 5 | CID000003966 | |
| Drug | dichloran | 3.14e-07 | 41 | 32 | 4 | CID000007430 | |
| Drug | NADP(H | 5.04e-07 | 527 | 32 | 8 | CID000000930 | |
| Drug | phenobarbital | 5.58e-07 | 360 | 32 | 7 | CID000004763 | |
| Drug | 8-MOP | 6.18e-07 | 118 | 32 | 5 | CID000004114 | |
| Drug | azo analog I | 7.14e-07 | 13 | 32 | 3 | CID006438575 | |
| Drug | chloral hydrate | 9.62e-07 | 129 | 32 | 5 | CID000002707 | |
| Drug | NSC9700 | 1.01e-06 | 578 | 32 | 8 | CID000005408 | |
| Drug | aminoglutethimide | 1.30e-06 | 137 | 32 | 5 | CID000002145 | |
| Drug | paraoxon | 3.14e-06 | 164 | 32 | 5 | CID000009395 | |
| Drug | 2,2,2-trichloroethanol | 3.27e-06 | 73 | 32 | 4 | CID000008259 | |
| Drug | NSC98537 | 3.43e-06 | 473 | 32 | 7 | CID000005410 | |
| Drug | felodipine | 3.64e-06 | 169 | 32 | 5 | CID000003333 | |
| Drug | rifampicin | 3.79e-06 | 306 | 32 | 6 | CID005381226 | |
| Drug | K-K-K | 4.31e-06 | 175 | 32 | 5 | CID000003823 | |
| Drug | metyrapone | 4.81e-06 | 179 | 32 | 5 | CID000004174 | |
| Drug | ebastine | 5.68e-06 | 25 | 32 | 3 | CID000003191 | |
| Drug | deferoxamine | 7.29e-06 | 343 | 32 | 6 | CID000002973 | |
| Drug | tolbutamide | 7.87e-06 | 198 | 32 | 5 | CID000005505 | |
| Drug | p-nitroanisole | 8.23e-06 | 92 | 32 | 4 | CID000007485 | |
| Drug | beta-naphthoflavone | 8.26e-06 | 200 | 32 | 5 | CID000002361 | |
| Drug | 2-naphthol | 8.59e-06 | 93 | 32 | 4 | CID000008663 | |
| Drug | benzo(a)pyrene | 9.30e-06 | 358 | 32 | 6 | CID000002336 | |
| Drug | AC1L1AL2 | 1.99e-05 | 115 | 32 | 4 | CID000001035 | |
| Drug | alpha-naphthoflavone | 2.20e-05 | 118 | 32 | 4 | CID000011790 | |
| Drug | AC1O5PIQ | 2.23e-05 | 39 | 32 | 3 | CID006438348 | |
| Drug | 6-trans-leukotriene B4 | 2.29e-05 | 247 | 32 | 5 | CID000000169 | |
| Drug | lorcaserin | 2.86e-05 | 6 | 32 | 2 | ctd:C506658 | |
| Drug | oltipraz | 3.96e-05 | 137 | 32 | 4 | CID000047318 | |
| Drug | 3-hydroxystearate | 4.00e-05 | 7 | 32 | 2 | CID005282907 | |
| Drug | obeticholic acid | 4.38e-05 | 283 | 32 | 5 | ctd:C464660 | |
| Drug | 2 E1 | 4.94e-05 | 145 | 32 | 4 | CID006102788 | |
| Drug | bisphenol S | 5.33e-05 | 8 | 32 | 2 | CID000006626 | |
| Drug | oxygen | 6.00e-05 | 499 | 32 | 6 | CID000000977 | |
| Drug | AC1MUNZL | 6.65e-05 | 56 | 32 | 3 | CID003643892 | |
| Drug | halothane | 7.17e-05 | 314 | 32 | 5 | CID000003562 | |
| Drug | AC1L1HMM | 7.23e-05 | 516 | 32 | 6 | CID000004196 | |
| Drug | 17-ODYA | 8.17e-05 | 60 | 32 | 3 | CID000001449 | |
| Drug | 18-HETE | 8.55e-05 | 10 | 32 | 2 | CID006442778 | |
| Drug | caffeine | 1.16e-04 | 562 | 32 | 6 | CID000002519 | |
| Drug | 5,6-epoxyeicosatrienoic acid | 1.19e-04 | 68 | 32 | 3 | CID000001778 | |
| Drug | 8(9)-EET | 1.24e-04 | 69 | 32 | 3 | CID000001901 | |
| Drug | delta-tocopherol | 1.25e-04 | 12 | 32 | 2 | CID000092094 | |
| Drug | 1-aminobenzotriazole | 1.35e-04 | 71 | 32 | 3 | CID000001367 | |
| Drug | 3-hydroxyhexadecanoic acid | 1.48e-04 | 13 | 32 | 2 | CID000301590 | |
| Drug | 1T-1S | 1.48e-04 | 13 | 32 | 2 | CID000405389 | |
| Drug | Hydrochlorothiazide [58-93-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.59e-04 | 196 | 32 | 4 | 1487_UP | |
| Drug | Deferoxamine mesylate [138-14-7]; Up 200; 6uM; MCF7; HT_HG-U133A | 1.71e-04 | 200 | 32 | 4 | 3936_UP | |
| Drug | veratraldehyde | 1.72e-04 | 14 | 32 | 2 | CID000008419 | |
| Drug | 7-BFC | 1.72e-04 | 14 | 32 | 2 | CID000848780 | |
| Drug | AC1L1F9Q | 1.75e-04 | 201 | 32 | 4 | CID000003144 | |
| Drug | C20H32O4 | 1.79e-04 | 78 | 32 | 3 | CID000001440 | |
| Drug | ketorolac tromethamine | 1.99e-04 | 15 | 32 | 2 | CID000084003 | |
| Drug | diamidine | 1.99e-04 | 15 | 32 | 2 | CID000008813 | |
| Drug | 7-ethoxycoumarin | 2.38e-04 | 86 | 32 | 3 | CID000035703 | |
| Drug | nifedipine | 2.64e-04 | 415 | 32 | 5 | CID000004485 | |
| Drug | AG213 | 2.64e-04 | 89 | 32 | 3 | CID005328803 | |
| Drug | 14(15)-EpETrE | 2.64e-04 | 89 | 32 | 3 | CID000001431 | |
| Drug | Androstane-3,17-diol | 2.89e-04 | 18 | 32 | 2 | ctd:D015113 | |
| Drug | DK-PGD2 | 2.89e-04 | 18 | 32 | 2 | CID005283036 | |
| Drug | pleuromutilin | 2.89e-04 | 18 | 32 | 2 | CID000031326 | |
| Drug | C1 11-32 | 2.89e-04 | 18 | 32 | 2 | CID000443077 | |
| Drug | C11131 | 2.89e-04 | 18 | 32 | 2 | CID000443076 | |
| Drug | Azamulinum | 2.89e-04 | 18 | 32 | 2 | CID003086060 | |
| Drug | 3-methylcholanthrene | 2.97e-04 | 231 | 32 | 4 | CID000001674 | |
| Drug | AC1L1BEQ | 3.00e-04 | 93 | 32 | 3 | CID000001407 | |
| Drug | anti-BaPDE | 3.12e-04 | 234 | 32 | 4 | CID000041322 | |
| Drug | imipramine | 3.17e-04 | 235 | 32 | 4 | CID000003696 | |
| Drug | DB75 | 3.22e-04 | 19 | 32 | 2 | CID000126437 | |
| Drug | T4-G | 3.22e-04 | 19 | 32 | 2 | CID000152424 | |
| Drug | propafenone | 3.50e-04 | 98 | 32 | 3 | CID000004932 | |
| Drug | AC1L1OBF | 3.58e-04 | 20 | 32 | 2 | CID000032736 | |
| Drug | estriol-16-glucuronide | 3.95e-04 | 21 | 32 | 2 | CID000122281 | |
| Drug | AC1L510Y | 4.34e-04 | 22 | 32 | 2 | CID000196040 | |
| Drug | 20-HETE | 4.41e-04 | 106 | 32 | 3 | CID005283157 | |
| Drug | estradiol-3-glucuronide | 4.75e-04 | 23 | 32 | 2 | CID000066651 | |
| Drug | Hymecromone | 5.63e-04 | 25 | 32 | 2 | ctd:D006923 | |
| Drug | lithocholic acid | 5.74e-04 | 116 | 32 | 3 | CID000009903 | |
| Drug | 20-hydroxyleukotriene B4 | 6.09e-04 | 26 | 32 | 2 | CID000001589 | |
| Drug | licochalcone A | 6.57e-04 | 27 | 32 | 2 | ctd:C070840 | |
| Drug | C14845 | 6.57e-04 | 27 | 32 | 2 | CID011954064 | |
| Drug | BP-9,10-oxide | 6.57e-04 | 27 | 32 | 2 | CID000037456 | |
| Drug | AC1L1BSF | 6.57e-04 | 27 | 32 | 2 | CID000001585 | |
| Disease | cholic acid glucuronide measurement | 3.42e-06 | 3 | 32 | 2 | EFO_0800574 | |
| Disease | X-25937 measurement | 6.83e-06 | 4 | 32 | 2 | EFO_0800937 | |
| Disease | X-24574 measurement | 2.38e-05 | 7 | 32 | 2 | EFO_0800897 | |
| Disease | deoxycholic acid glucuronide measurement | 3.18e-05 | 8 | 32 | 2 | EFO_0800575 | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 4.08e-05 | 9 | 32 | 2 | EFO_0800562 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 5.10e-05 | 10 | 32 | 2 | EFO_0022090 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 6.23e-05 | 11 | 32 | 2 | EFO_0801531 | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 7.47e-05 | 12 | 32 | 2 | EFO_0800291 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 8.82e-05 | 13 | 32 | 2 | EFO_0800293 | |
| Disease | X-19141 measurement | 8.82e-05 | 13 | 32 | 2 | EFO_0800799 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 1.03e-04 | 14 | 32 | 2 | EFO_0800283 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 1.72e-04 | 18 | 32 | 2 | EFO_0800288 | |
| Disease | etiocholanolone glucuronide measurement | 1.93e-04 | 19 | 32 | 2 | EFO_0800362 | |
| Disease | androsterone glucuronide measurement | 2.14e-04 | 20 | 32 | 2 | EFO_0800317 | |
| Disease | X-24947 measurement | 2.60e-04 | 22 | 32 | 2 | EFO_0800910 | |
| Disease | metabolite measurement | 3.19e-04 | 560 | 32 | 5 | EFO_0004725 | |
| Disease | epiandrosterone sulfate measurement | 3.37e-04 | 25 | 32 | 2 | EFO_0021120 | |
| Disease | androsterone sulfate measurement | 5.89e-04 | 33 | 32 | 2 | EFO_0021117 | |
| Disease | omega-6:omega-3 polyunsaturated fatty acid ratio | 1.35e-03 | 50 | 32 | 2 | EFO_0010732 | |
| Disease | ecosanoids measurement | 1.63e-03 | 55 | 32 | 2 | EFO_0020044 | |
| Disease | hypertension (biomarker_via_orthology) | 1.89e-03 | 227 | 32 | 3 | DOID:10763 (biomarker_via_orthology) | |
| Disease | Liver diseases | 2.78e-03 | 72 | 32 | 2 | C0023895 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DRVPEYPAWFEPFVI | 1136 | Q9UPW8 | |
| FYSQEPFLEWVPCLP | 331 | Q9H7T0 | |
| VYFNFFVWVLPPLLL | 181 | P30542 | |
| DTRIFFVNPAPPYLW | 111 | O00468 | |
| WPAAQFVNFLFVPPQ | 151 | Q567V2 | |
| VFLNCFFNWPLEPFP | 221 | Q8N370 | |
| LPWLFTFNVKFYPPD | 286 | O43491 | |
| FIYVWPFTNFPIDKV | 256 | Q96R72 | |
| DLVIFQFPLYWFSVP | 96 | P16083 | |
| LCPFGFEVYPFQVAW | 16 | Q9Y4U1 | |
| PCPDVYWFPIFTEVA | 551 | Q02809 | |
| VFLYNAFPWIGILPF | 226 | Q6VVX0 | |
| PTVWPDPEVYDPFRF | 431 | Q9HBI6 | |
| PTVWPDPEVYDPFRF | 431 | Q9HCS2 | |
| PAVWPDPEVYDPFRF | 431 | P78329 | |
| PSRYWLPAFFFPQAF | 3321 | Q0VDD8 | |
| PAVWPDPEVYDPFRF | 431 | Q08477 | |
| FIPCIYIYTWPFTPF | 251 | Q15615 | |
| PWLEIPPFVMFLFSY | 21 | Q9GZK3 | |
| WFDVYDAFPPLREPV | 31 | Q9Y3D9 | |
| ITPPLVFDIFIWFAY | 281 | O14804 | |
| LFWVFQIPAPFPEYV | 261 | Q96AM1 | |
| VFFTTLPWIIYGIFP | 491 | Q63ZE4 | |
| AFPQFFIVYWLAPSL | 231 | Q8NBQ7 | |
| VVLPKEFPVYLWQPF | 156 | Q9BZQ8 | |
| YAFNPILDPWVFILF | 281 | P43119 | |
| WLYFPDFIVRPNPVF | 1211 | Q9H5I5 | |
| IPFSFYYPWELAIVP | 51 | Q9UKJ0 | |
| FIPEFEKQYPEFPWT | 531 | Q14166 | |
| PFDPRNEIYILFNPW | 236 | P22735 | |
| TYWDFEFPRPFLPNV | 261 | P54855 | |
| TYWDFEFPRPFLPNV | 261 | O75795 | |
| WVCPLTIFNPDYFIP | 306 | Q5GH70 |